Quick Summary of Abbvie GK Japan ver.2015

SKU:
$100.00
$100.00
Unavailable
per item
This report is good for a company/person who want to quickly learn about keys for this company.

  • Company Overview
  • Financial Summary
  • Main Therapeutic Area
  • Key Products
  • Pipeline
  • Organization (if any)
  • Strategy
  • Update (if any)

AbbVie GK operates as a Japanese subsidiary of AbbVie Inc.  The biopharmaceutical company that was spun off from Abbott Japan, has officially begun its operations on January 1, 2013. Its main therapeutic areas are immunology, oncology, CNS, women’s health, and renal disease.